Zurcher Kantonalbank (Zurich Cantonalbank) Bei Gene, Ltd. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$158.67 - $201.58 $1,110 - $1,411	-7 Reduced 10.45%	60 $10,000
Q3 2023 Oct 25, 2023	SELL	$179.87 - $225.13 $3,957 - $4,952	-22 Reduced 24.72%	67 $12,000
Q2 2023 Aug 07, 2023	SELL	$178.3 - $266.78 $4,814 - $7,203	-27 Reduced 23.28%	89 $15,000
Q1 2023 May 08, 2023	BUY	$215.53 - $274.5 $25,001 - $31,842	116 New	116 $25,000
Q3 2022 Nov 09, 2022	BUY	$131.8 - $202.24 $172,262 - $264,327	1,307 Added 5.68%	24,324 $3.28 Million
Q2 2022 Aug 09, 2022	BUY	$121.11 - $216.05 $251,061 - $447,871	2,073 Added 9.9%	23,017 $3.73 Million
Q1 2022 Apr 21, 2022	BUY	$146.52 - $269.56 $578,460 - $1.06 Million	3,948 Added 23.23%	20,944 $3.95 Million
Q4 2021 Feb 01, 2022	BUY	$248.56 - $389.34 $295,289 - $462,535	1,188 Added 7.52%	16,996 $4.61 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $93,100 - $150,371	373 Added 2.42%	15,808 $5.74 Million
Q2 2021 Jul 30, 2021	SELL	$292.75 - $367.01 $890,252 - $1.12 Million	-3,041 Reduced 16.46%	15,435 $5.3 Million
Q1 2021 May 03, 2021	BUY	$260.64 - $382.12 $1.7 Million - $2.5 Million	6,539 Added 54.78%	18,476 $6.43 Million
Q4 2020 Jan 28, 2021	SELL	$221.31 - $316.61 $410,308 - $586,994	-1,854 Reduced 13.44%	11,937 $3.08 Million
Q3 2020 Nov 06, 2020	BUY	$189.18 - $286.44 $452,896 - $685,737	2,394 Added 21.01%	13,791 $3.95 Million
Q2 2020 Jul 28, 2020	SELL	$123.9 - $195.41 $10,159 - $16,023	-82 Reduced 0.71%	11,397 $2.15 Million
Q1 2020 May 06, 2020	BUY	$121.84 - $173.19 $138,897 - $197,436	1,140 Added 11.03%	11,479 $1.41 Million
Q4 2019 Jan 21, 2020	BUY	$115.78 - $208.34 $101,075 - $181,880	873 Added 9.22%	10,339 $1.71 Million
Q3 2019 Oct 18, 2019	BUY	$120.61 - $148.29 $140,028 - $172,164	1,161 Added 13.98%	9,466 $1.16 Million
Q2 2019 Jul 30, 2019	BUY	$113.99 - $146.86 $109,658 - $141,279	962 Added 13.1%	8,305 $1.03 Million
Q4 2018 Jan 25, 2019	BUY	$107.01 - $175.15 $785,774 - $1.29 Million	7,343 New	7,343 $1.03 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.89 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.15 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$927 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$891 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$664 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account